Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
M.D. Anderson Cancer Center
Emory University
Jonsson Comprehensive Cancer Center
Northwell Health
Lumos Pharma
Mayo Clinic
Canadian Cancer Trials Group
Canadian Cancer Trials Group
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
AbbVie
Center Trials & Treatment Europe
Case Comprehensive Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
M.D. Anderson Cancer Center
Duke University
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
Lumos Pharma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Virginia Commonwealth University
Dana-Farber Cancer Institute
European Organisation for Research and Treatment of Cancer - EORTC
Stanford University
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Cancer Research UK
University of California, San Francisco
Celldex Therapeutics
University of California, San Francisco
European Organisation for Research and Treatment of Cancer - EORTC
Dana-Farber Cancer Institute
Radiation Therapy Oncology Group
Center for Neurosciences, Tucson